These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 30167776)

  • 1. Post-mortem in situ stability of serum markers of cerebral damage and acute phase response.
    Ondruschka B; Woydt L; Bernhard M; Franke H; Kirsten H; Löffler S; Pohlers D; Hammer N; Dreßler J
    Int J Legal Med; 2019 May; 133(3):871-881. PubMed ID: 30167776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute phase response after fatal traumatic brain injury.
    Ondruschka B; Schuch S; Pohlers D; Franke H; Dreßler J
    Int J Legal Med; 2018 Mar; 132(2):531-539. PubMed ID: 29306988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing Protein Biomarkers to Detect Lethal Acute Traumatic Brain Injuries in Cerebrospinal Fluid.
    Zwirner J; Bohnert S; Franke H; Garland J; Hammer N; Möbius D; Tse R; Ondruschka B
    Biomolecules; 2021 Oct; 11(11):. PubMed ID: 34827575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of S100B protein, neuron-specific enolase, and glial fibrillary acidic protein in the evaluation of hypoxic brain injury in acute carbon monoxide poisoning.
    Akdemir HU; Yardan T; Kati C; Duran L; Alacam H; Yavuz Y; Okuyucu A
    Hum Exp Toxicol; 2014 Nov; 33(11):1113-20. PubMed ID: 24505052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain injury markers: S100 calcium-binding protein B, neuron-specific enolase and glial fibrillary acidic protein in children with diabetic ketoacidosis.
    Çatlı G; Anık A; Acar S; Küme T; Karabulut M; Çalan ÖG; Dündar BN; Abacı A
    Pediatr Diabetes; 2018 Aug; 19(5):1000-1006. PubMed ID: 29484801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury.
    Vos PE; Lamers KJ; Hendriks JC; van Haaren M; Beems T; Zimmerman C; van Geel W; de Reus H; Biert J; Verbeek MM
    Neurology; 2004 Apr; 62(8):1303-10. PubMed ID: 15111666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-mortem biochemistry of NSE and S100B: A supplemental tool for detecting a lethal traumatic brain injury?
    Sieber M; Dreßler J; Franke H; Pohlers D; Ondruschka B
    J Forensic Leg Med; 2018 Apr; 55():65-73. PubMed ID: 29471249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of selected markers of inflammation and blood-brain barrier damage for short-term ischemic stroke prognosis.
    Lasek-Bal A; Jedrzejowska-Szypulka H; Student S; Warsz-Wianecka A; Zareba K; Puz P; Bal W; Pawletko K; Lewin-Kowalik J
    J Physiol Pharmacol; 2019 Apr; 70(2):. PubMed ID: 31356182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of Cerebral Biomarkers Proving Traumatic Brain Injuries in Post-Mortem Body Fluids.
    Ondruschka B; Sieber M; Kirsten H; Franke H; Dreßler J
    J Neurotrauma; 2018 Sep; 35(17):2044-2055. PubMed ID: 29732941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value of Serum Levels of S100 Calcium-Binding Protein B, Neuron-Specific Enolase, and Interleukin-6 in Pediatric Patients with Traumatic Brain Injury.
    Park SH; Hwang SK
    World Neurosurg; 2018 Oct; 118():e534-e542. PubMed ID: 30257306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S100B and NSE as useful postmortem biochemical markers of traumatic brain injury in autopsy cases.
    Ondruschka B; Pohlers D; Sommer G; Schober K; Teupser D; Franke H; Dressler J
    J Neurotrauma; 2013 Nov; 30(22):1862-71. PubMed ID: 23796187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Pilot Study of the Use of Dexmedetomidine for the Control of Delirium by Reducing the Serum Concentrations of Brain-Derived Neurotrophic Factor, Neuron-Specific Enolase, and S100B in Polytrauma Patients.
    Li Y; Yu ZX; Ji MS; Yan J; Cai Y; Liu J; Yang HF; Jin ZC
    J Intensive Care Med; 2019 Aug; 34(8):674-681. PubMed ID: 28569132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Levels of S100b and NSE Proteins in Patients with Non-Transfusion-Dependent Thalassemia as Biomarkers of Brain Ischemia and Cerebral Vasculopathy.
    Kanavaki A; Spengos K; Moraki M; Delaporta P; Kariyannis C; Papassotiriou I; Kattamis A
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29244749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Serum Protein Biomarker Panel Improves Outcome Prediction in Human Traumatic Brain Injury.
    Thelin E; Al Nimer F; Frostell A; Zetterberg H; Blennow K; Nyström H; Svensson M; Bellander BM; Piehl F; Nelson DW
    J Neurotrauma; 2019 Oct; 36(20):2850-2862. PubMed ID: 31072225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple indicators model of long-term mortality in traumatic brain injury.
    Gradisek P; Osredkar J; Korsic M; Kremzar B
    Brain Inj; 2012; 26(12):1472-81. PubMed ID: 22721420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of serum Neuron-specific enolase, S100B, myelin basic protein and glial fibrilliary acidic protein as brain specific proteins in children with autism spectrum disorder.
    Esnafoglu E; Ayyıldız SN; Cırrık S; Erturk EY; Erdil A; Daglı A; Noyan T
    Int J Dev Neurosci; 2017 Oct; 61():86-91. PubMed ID: 28711670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glial and neuronal serum markers after controlled cortical impact injury in the rat.
    Woertgen C; Rothoerl RD; Wiesmann M; Missler U; Brawanski A
    Acta Neurochir Suppl; 2002; 81():205-7. PubMed ID: 12168305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of serum biomarkers to predict cerebral hypoxia after severe traumatic brain injury.
    Stein DM; Lindell AL; Murdock KR; Kufera JA; Menaker J; Bochicchio GV; Aarabi B; Scalea TM
    J Neurotrauma; 2012 Apr; 29(6):1140-9. PubMed ID: 22360297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers of Cerebral Injury and Inflammation in Pediatric Tuberculous Meningitis.
    Rohlwink UK; Mauff K; Wilkinson KA; Enslin N; Wegoye E; Wilkinson RJ; Figaji AA
    Clin Infect Dis; 2017 Oct; 65(8):1298-1307. PubMed ID: 28605426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Explorative investigation of biomarkers of brain damage and coagulation system activation in clinical stroke differentiation.
    Undén J; Strandberg K; Malm J; Campbell E; Rosengren L; Stenflo J; Norrving B; Romner B; Lindgren A; Andsberg G
    J Neurol; 2009 Jan; 256(1):72-7. PubMed ID: 19221847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.